USFDA completes inspection at Granules India’s Hyderabad facility

17 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Granules India’s facility in Gagillapur located in Hyderabad, Telangana, India on February 14, 2020 with two observations. The company will respond to these observations within the stipulated time.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

589.00 6.70 (1.15%)
20-Mar-2026 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.25
Dr. Reddys Lab 1295.45
Cipla 1256.00
Zydus Lifesciences 891.35
Lupin 2319.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×